Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

801
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
801
Quality Assurance01:19

Quality Assurance

115
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practice patterns of DOAC high-intensity period following parenteral lead-in treatment for venous thromboembolism.

Journal of thrombosis and thrombolysis·2026
Same author

Long-Acting Insulin and Hypoglycemia in Critically Ill Patients with Diabetes: A Sensitivity Analysis.

Journal of intensive care medicine·2026
Same author

Academic conference posters: A systematic review.

Innovations in pharmacy·2026
Same author

Research and Scholarly Methods: Scoping Reviews.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Evaluation of the Safety and Effectiveness of Two Nomograms for the Management of Diabetic Ketoacidosis.

Hospital pharmacy·2026
Same author

Gabapentinoids in Chronic Kidney Disease: A Closer Look at Respiratory Risk.

The Annals of pharmacotherapy·2025

Related Experiment Video

Updated: Jun 7, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K

Optimizing Heparin Quality Assurance Utilizing Electronic Data Abstraction.

Elizabeth Lemanske1,2, Justin Zimmerman1,2, Paul Dobry1,2

  • 1Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA.

The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|November 21, 2024
PubMed
Summary
This summary is machine-generated.

Manual and electronic data collection for heparin quality assurance showed good agreement for therapeutic aPTT, but poor agreement for clinical outcomes. A hybrid approach improves efficiency in heparin management.

Keywords:
electronic health recordsheparinmedication safetyquality assurancereproducibility of results

More Related Videos

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
09:12

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

2.8K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

10.9K

Related Experiment Videos

Last Updated: Jun 7, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K
Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
09:12

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

2.8K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

10.9K

Area of Science:

  • Pharmacology
  • Health Informatics
  • Quality Improvement

Background:

  • Heparin, a high-risk medication, requires careful management due to patient variability.
  • Systematic data analysis is crucial for optimizing heparin therapy and enhancing patient safety.
  • Efficient data collection processes are needed to streamline hospital quality assurance programs for anticoagulation.

Purpose of the Study:

  • To evaluate the concordance between manual and electronic data abstraction methods for heparin quality assurance.
  • To identify discrepancies in data collection for key performance indicators related to heparin therapy.

Main Methods:

  • A single-center, observational cohort study of 288 patients receiving unfractionated heparin.
  • Comparison of data manually extracted from pharmacist forms and electronic medical records against data from an institutional data warehouse.
  • Assessment of agreement using kappa statistics for therapeutic activated partial thromboplastin time (aPTT) achievement and clinical outcomes.

Main Results:

  • High agreement (kappa = 0.86) was observed for achieving therapeutic aPTT within 24 hours.
  • Substantial agreement (kappa = 0.69) was found for therapeutic or supratherapeutic aPTT within 24 hours.
  • Poor agreement was noted for identifying subsequent heparin boluses (kappa = 0.13) and new venous thromboembolism (VTE) cases (kappa = -0.01).

Conclusions:

  • The reliability of data collection for heparin quality assurance varies significantly between manual and electronic methods.
  • A hybrid approach combining manual and electronic data abstraction has been implemented to enhance efficiency.
  • Further research is necessary to generalize findings and improve electronic data capture for clinical outcomes.